Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer

PURPOSE: Combination of biological therapy and chemotherapy improves the survival of patients with metastatic colorectal cancer (mCRC). However, the optimal biological therapy sequence remains unclear. In this retrospective study, we evaluated the clinical outcomes of patients with mCRC treated with...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Med
Main Authors: Hsu, Hung‐Chih, Liu, Yu‐Chun, Wang, Chuang‐Wei, Chou, Wen-Chi, Hsu, Yu-Jen, Chiang, Jy-Ming, Lin, Yung-Chang, Yang, Tsai-Sheng
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Clinical Cancer Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6601597/
https://ncbi.nlm.nih.gov/pubmed/31090176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2235
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker